Cargando…
Molecular Mechanism of SAHA on Regulation of Autophagic Cell Death in Tamoxifen-Resistant MCF-7 Breast Cancer Cells
Objective: Tamoxifen is currently used for the treatment of estrogen receptor-positive breast cancer patients, but acquired resistance to tamoxifen is a critical problem in breast cancer therapy. Suberoylanilide hydroxamic acid (SAHA) is a prototype of the newly developed HDAC inhibitor. The aim of...
Autores principales: | Lee, Young Ju, Won, A Jin, Lee, Jaewon, Jung, Jee H., Yoon, Sungpil, Lee, Byung Mu, Kim, Hyung Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498753/ https://www.ncbi.nlm.nih.gov/pubmed/23155362 http://dx.doi.org/10.7150/ijms.5011 |
Ejemplares similares
-
Anticancer Effects of a New SIRT Inhibitor, MHY2256, against Human Breast Cancer MCF-7 Cells via Regulation of MDM2-p53 Binding
por: Park, Eun Young, et al.
Publicado: (2016) -
Differential Mechanisms of Cell Death Induced by HDAC Inhibitor SAHA and MDM2 Inhibitor RG7388 in MCF-7 Cells
por: Natarajan, Umamaheswari, et al.
Publicado: (2018) -
Vitamin C suppresses cell death in MCF-7 human breast cancer cells induced by tamoxifen
por: Subramani, Tamilselvan, et al.
Publicado: (2014) -
4,6′-Anhydrooxysporidinone from Fusarium lateritium SSF2 Induces Autophagic and Apoptosis Cell Death in MCF-7 Breast Cancer Cells
por: Lee, Dahae, et al.
Publicado: (2021) -
Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells
por: Ajabnoor, G M A, et al.
Publicado: (2012)